Markets
Clinuvel Pharmaceuticals Limited (CUVL)
CUVLNASDAQ-GSMiscellaneous
$4.90
-0.0700 (-1.41%) today
Closed, Nov 17, 4:00 PM ET
-1.41% 1D
- Market cap
- $252.14m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- 0.71%
- Day range
- –
- 52-week range
- $4.81 to $8.20
- Average volume
- –
- Previous close
- $4.97
Financials
No quarterly figures from the source.
News
1 latestThe company
CLINUVEL is a global biopharmaceutical company focused on developing and delivering innovative therapies for patients with genetic, metabolic, and dermatological disorders. The Company's portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo. CLINUVEL is listed on the Australian Securities Exchange (ASX: CUV) and the Nasdaq Stock Market (Nasdaq: CUVL).
- Sector
- Miscellaneous
- Industry
- Miscellaneous
- Exchange
- NASDAQ-GS
- Region
- Australia and South Pacific
- Website
- clinuvel.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.